Rigvir Group concludes an agreement for the development of Uveal Melanoma Project

19 October 2020

Rigvir Group has signed a collaboration agreement with the French company STRAD HEALTHCARE for the development of the Uveal Melanoma Project.
The collaboration aims to develop the ECHO-7 virus for the treatment of uveal melanoma.
STRAD HEALTHCARE President Ph.D. Stéphane Altaba will act as the Uveal Melanoma Project leader as well.
Uveal melanoma is cancer in the eye - an aggressive tumor with a high risk of metastasis, a rare disease with high medical needs.

Contacts for Media Inquiries

Rigvir Group
Address: Atlasa street 7C, Riga, Latvia, LV-1026
Phone: +371 67 716 132
E-mail: pr@rigvir.com